Cyclophosphamide is 4-hydroxylated by CYP2B6

Stable Identifier
R-HSA-211991
Type
Reaction
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Cyclophosphamide (CPA) is an alkylating agent used in cancer chemotherapy and an immunosuppressant. CYP2B6 converts CPA to the active metabolite 4-hydroxy-CPA.

Literature References
PubMed ID Title Journal Year
12629583 Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation

Lundgren, S, Griskevicius, L, Xie, HJ, Terelius, Y, Rane, A, Yasar, U, Hassan, M

Pharmacogenomics J 2003
Participants
Participates
Catalyst Activity

monooxygenase activity of Cytochrome P450 (CYP2B6 based) [endoplasmic reticulum membrane]

Orthologous Events
Authored
Reviewed
Created
Cite Us!